These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38386957)

  • 1. SMART-ESAS: Smartphone Monitoring and Assessment in Real Time of Edmonton Symptom Assessment System Scores for Patients With Cancer.
    Nagpal C; Sharma A; Bakhshi S; Malik PS; Gupta H; Mittal C; Gund S; Kumar A; Sharma A; Pushpam D; Khurana S; Pramanik R; Gupta N; Batra A
    JCO Glob Oncol; 2024 Feb; 10():e2300447. PubMed ID: 38386957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the Edmonton Symptom Assessment System in Korean patients with cancer.
    Kwon JH; Nam SH; Koh S; Hong YS; Lee KH; Shin SW; Hui D; Park KW; Yoon SY; Won JY; Chisholm G; Bruera E
    J Pain Symptom Manage; 2013 Dec; 46(6):947-56. PubMed ID: 23628516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Province-Wide Analysis of Patient-Reported Outcomes for Stage IV Non-Small Cell Lung Cancer.
    Tjong MC; Doherty M; Tan H; Chan WC; Zhao H; Hallet J; Darling G; Kidane B; Wright FC; Mahar A; Davis LE; Delibasic V; Parmar A; Mittmann N; Coburn NG; Louie AV
    Oncologist; 2021 Oct; 26(10):e1800-e1811. PubMed ID: 34216415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Edmonton symptom assessment scale: Italian validation in two palliative care settings.
    Moro C; Brunelli C; Miccinesi G; Fallai M; Morino P; Piazza M; Labianca R; Ripamonti C
    Support Care Cancer; 2006 Jan; 14(1):30-7. PubMed ID: 15937688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Italian version of the Edmonton Symptom Assessment System (ESAS)-Total Care (TC): development and psychometric validation in patients undergoing cancer treatment or follow-up.
    Ripamonti C; Leporati R; De Feo G; Di Pede P; Toffolatti L; Guglielmo M; La Carpia D; Miccinesi G; Chiesi F
    Support Care Cancer; 2022 Mar; 30(3):1923-1933. PubMed ID: 34623487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined cancer patient-reported symptom and health utility tool for routine clinical implementation: a real-world comparison of the ESAS and EQ-5D in multiple cancer sites.
    Moskovitz M; Jao K; Su J; Brown MC; Naik H; Eng L; Wang T; Kuo J; Leung Y; Xu W; Mittmann N; Moody L; Barbera L; Devins G; Li M; Howell D; Liu G
    Curr Oncol; 2019 Dec; 26(6):e733-e741. PubMed ID: 31896943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified Edmonton Symptom Assessment System including constipation and sleep: validation in outpatients with cancer.
    Hannon B; Dyck M; Pope A; Swami N; Banerjee S; Mak E; Bryson J; Rodin G; Ridley J; Lo C; Le LW; Zimmermann C
    J Pain Symptom Manage; 2015 May; 49(5):945-52. PubMed ID: 25523890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptom Evolution in Patients with Esophageal and Gastric Cancer Receiving Palliative Chemotherapy: A Population-Based Study.
    Merchant SJ; Kong W; Brundage M; Booth CM
    Ann Surg Oncol; 2021 Jan; 28(1):79-87. PubMed ID: 33140252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Brazilian Version of the Edmonton Symptom Assessment System (ESAS) Is a Feasible, Valid and Reliable Instrument for the Measurement of Symptoms in Advanced Cancer Patients.
    Paiva CE; Manfredini LL; Paiva BS; Hui D; Bruera E
    PLoS One; 2015; 10(7):e0132073. PubMed ID: 26154288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Edmonton Symptom Assessment System: Ascites Modification.
    Mori M; Morita T; Yokomichi N; Nitto A; Takahashi N; Miyamoto S; Nishie H; Matsuoka J; Sakurai H; Ishihara T; Tarumi Y; Ogawa A
    J Pain Symptom Manage; 2018 Jun; 55(6):1557-1563. PubMed ID: 29581035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptom correlates of dyspnea in advanced cancer patients using the Edmonton Symptom Assessment System.
    McKenzie E; Zhang L; Chan S; Zaki P; Razvi Y; Tsao M; Barnes E; Drost L; Yee C; Hwang M; DeAngelis C; Chow E
    Support Care Cancer; 2020 Jan; 28(1):87-98. PubMed ID: 30982093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of the revised Edmonton Symptom Assessment System (ESAS-r) and the Patient-Reported Functional Status (PRFS) in lung cancer patients.
    Yogananda MN; Muthu V; Prasad KT; Kohli A; Behera D; Singh N
    Support Care Cancer; 2018 Mar; 26(3):767-775. PubMed ID: 29027005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of automated screening with Edmonton Symptom Assessment System (ESAS) on health-related quality of life, supportive care needs, and patient satisfaction with care in 268 ambulatory cancer patients.
    Diplock BD; McGarragle KMC; Mueller WA; Haddad S; Ehrlich R; Yoon DA; Cao X; Al-Allaq Y; Karanicolas P; Fitch MI; Myers J; Mitchell AJ; Ellis JWM
    Support Care Cancer; 2019 Jan; 27(1):209-218. PubMed ID: 29931490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of a Symptom Assessment Tool in Shaping Patient-Physician Communication in Palliative Care.
    Brooks JV; Poague C; Formagini T; Sinclair CT; Nelson-Brantley HV
    J Pain Symptom Manage; 2020 Jan; 59(1):30-38. PubMed ID: 31494177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-screening of patient-reported symptoms using the Edmonton Symptom Assessment System in outpatient palliative cancer care.
    Lee G; Kim HS; Lee SW; Park YR; Kim EH; Lee B; Hu YJ; Kim KA; Kim D; Cho HY; Kang B; Choi HJ
    Eur J Cancer Care (Engl); 2020 Nov; 29(6):e13305. PubMed ID: 33016473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing the feasibility of using the Edmonton Symptom Assessment System (ESAS) to assess caregiver symptom burden.
    Tanco K; Vidal M; Arthur J; Delgado Guay M; Hui D; Liu D; Chisholm G; Bruera E
    Palliat Support Care; 2018 Feb; 16(1):14-22. PubMed ID: 28264740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of routine Edmonton Symptom Assessment System (ESAS) use on overall survival in cancer patients: Results of a population-based retrospective matched cohort analysis.
    Barbera L; Sutradhar R; Seow H; Mittmann N; Howell D; Earle CC; Li Q; Thiruchelvam D
    Cancer Med; 2020 Oct; 9(19):7107-7115. PubMed ID: 32794634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptom burden in patients with common cancers near end-of-life and its associations with clinical characteristics: a real-world study.
    Batra A; Yang L; Boyne DJ; Harper A; Cuthbert CA; Cheung WY
    Support Care Cancer; 2021 Jun; 29(6):3299-3309. PubMed ID: 33104922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychometric Validation of the Edmonton Symptom Assessment System in Chinese Patients.
    Dong Y; Chen H; Zheng Y; Guo Y; Kwon JH; Liu E; Guo H; Bruera E
    J Pain Symptom Manage; 2015 Nov; 50(5):712-17.e2. PubMed ID: 26386188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishing Cutoff Points for Defining Symptom Severity Using the Edmonton Symptom Assessment System-Revised Japanese Version.
    Yamaguchi T; Morita T; Nitto A; Takahashi N; Miyamoto S; Nishie H; Matsuoka J; Sakurai H; Ishihara T; Tarumi Y; Ogawa A
    J Pain Symptom Manage; 2016 Feb; 51(2):292-7. PubMed ID: 26598039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.